355 related articles for article (PubMed ID: 22719141)
1. Implantable cardioverter-defibrillators: indications and unresolved issues.
Kedia R; Saeed M
Tex Heart Inst J; 2012; 39(3):335-41. PubMed ID: 22719141
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study.
Christensen AM; Bjerre J; Schou M; Jons C; Vinther M; Gislason GH; Johansen JB; Nielsen JC; Petersen HH; Riahi S; Ruwald AC
Europace; 2019 Mar; 21(3):465-474. PubMed ID: 30535192
[TBL] [Abstract][Full Text] [Related]
4. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
Stavrakis S; Asad Z; Reynolds D
J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
[TBL] [Abstract][Full Text] [Related]
5. Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.
Thavikulwat AC; Tomson TT; Knight BP; Bonow RO; Choudhury L
J Cardiovasc Electrophysiol; 2016 Aug; 27(8):953-60. PubMed ID: 27138377
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.
Santharam S; Hudsmith L; Thorne S; Clift P; Marshall H; De Bono J
Europace; 2017 Mar; 19(3):407-413. PubMed ID: 27234868
[TBL] [Abstract][Full Text] [Related]
7. The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?
Botto GL; Forleo GB; Capucci A; Solimene F; Vado A; Bertero G; Palmisano P; Pisanò E; Rapacciuolo A; Infusino T; Vicentini A; Viscusi M; Ferrari P; Talarico A; Russo G; Boriani G; Padeletti L; Lovecchio M; Valsecchi S; D'Onofrio A;
Europace; 2017 Nov; 19(11):1826-1832. PubMed ID: 28011803
[TBL] [Abstract][Full Text] [Related]
8. Primary Prevention of Sudden Cardiac Death Early Post-Myocardial Infarction: Root Cause Analysis for Implantable Cardioverter-Defibrillator Failure and Currently Available Options.
Elayi CS; Charnigo RJ; Heron PM; Lee BK; Olgin JE
Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630173
[No Abstract] [Full Text] [Related]
9. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death].
Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE
Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768
[TBL] [Abstract][Full Text] [Related]
10. Implantable device therapy.
Goldenberg I; Moss AJ
Prog Cardiovasc Dis; 2008; 50(6):449-74. PubMed ID: 18474287
[TBL] [Abstract][Full Text] [Related]
11. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
Akel T; Lafferty J
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469
[TBL] [Abstract][Full Text] [Related]
12. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
[TBL] [Abstract][Full Text] [Related]
13. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long-Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator (the eCTOpy-in-ICD Study).
van Dongen IM; Yilmaz D; Elias J; Claessen BEPM; Delewi R; Knops RE; Wilde AAM; van Erven L; Schalij MJ; Henriques JPS
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720502
[TBL] [Abstract][Full Text] [Related]
15. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
Herman D; Stros P; Curila K; Kebza V; Osmancik P
Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
[TBL] [Abstract][Full Text] [Related]
16. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
[TBL] [Abstract][Full Text] [Related]
17. Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network.
Greenlee RT; Go AS; Peterson PN; Cassidy-Bushrow AE; Gaber C; Garcia-Montilla R; Glenn KA; Gupta N; Gurwitz JH; Hammill SC; Hayes JJ; Kadish A; Magid DJ; McManus DD; Multerer D; Powers JD; Reifler LM; Reynolds K; Schuger C; Sharma PP; Smith DH; Suits M; Sung SH; Varosy PD; Vidaillet HJ; Masoudi FA
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581222
[TBL] [Abstract][Full Text] [Related]
18. The implantable cardioverter-defibrillator: An update.
Miller JD; Yousuf O; Berger RD
Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255
[TBL] [Abstract][Full Text] [Related]
19. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
[TBL] [Abstract][Full Text] [Related]
20. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy.
DeWitt ES; Triedman JK; Cecchin F; Mah DY; Abrams DJ; Walsh EP; Gauvreau K; Alexander ME
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1057-63. PubMed ID: 25262116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
